Kilroy Realty Corporation (NYSE: KRC), a leading West Coast office and life science REIT, reported a decline in first-quarter earnings, reflecting ongoing challenges in the commercial real estate sector as companies continue to reassess their office space needs in a post-pandemic landscape.
Financial Results Miss Expectations
The San Francisco-based real estate investment trust announced net income of $43.7 million for the quarter ended March 31, 2025, representing a 21.6 percent decrease from $55.7 million reported in the same period last year. This marks the third consecutive quarter of year-over-year earnings decline for the company.
Net Operating Income (NOI) decreased by $7.3 million, or 3.9 percent, to $180.2 million compared to $187.6 million in Q1 2024. The reduction was primarily driven by lower occupancy rates and reduced rental income across the company’s stabilized portfolio.
Occupancy and Leasing Challenges
Occupancy in Kilroy’s stabilized portfolio decreased to 81.4 percent as of March 31, 2025, down from 84.5 percent in the comparable period of 2024. This decline was most pronounced in the San Francisco Bay Area and Seattle markets, where occupancy rates stood at 86.8 percent and 78.6 percent, respectively.
The company executed 244,189 square feet of new and renewal leases during the quarter. However, leasing spreads continued to trend negative, with a 15.8 percent decrease in GAAP rents and an even steeper 23.0 percent decline in cash rents compared to expiring leases, highlighting the ongoing pressure on office rental rates.
The company’s retention rate also dropped to 19.3 percent, though this improves to 33.9 percent when including subleases, indicating that while tenants are vacating direct leases, many are finding ways to maintain presence in Kilroy’s properties through subleasing arrangements.
Balance Sheet and Liquidity Position
Despite earnings challenges, Kilroy maintained a relatively strong balance sheet with $146.7 million in cash and cash equivalents and $1.1 billion available under its unsecured revolving credit facility as of quarter-end. Total debt as a percentage of market capitalization stood at 54.2 percent, based on the closing share price of $32.76 on March 31, 2025.
The company faces no significant debt maturities until late 2025, when its $200 million term loan facility becomes due, though this includes extension options. This favorable maturity schedule provides financial flexibility as the company navigates the current market environment.
Development Activities Continue Despite Headwinds
Despite the earnings decline, Kilroy maintained its commitment to its development pipeline, investing $55.3 million in development and redevelopment projects during the quarter. The company expects to spend an additional $50 million to $150 million on development throughout the remainder of 2025.
Key projects include the 875,000-square-foot Phase 2 of Kilroy Oyster Point in South San Francisco, which reached the tenant improvement phase during Q1, and two life science conversions totaling approximately 100,000 square feet in San Diego and Menlo Park.
The Form 10-Q filing indicates that Kilroy Oyster Point Phase 2 “encompasses approximately 875,000 square feet of office and life science space across three buildings with a total estimated investment of $1.0 billion.” The company expects this property “to be added to the stabilized portfolio upon the completion of the 12-month lease up period which is expected to end in the first quarter of 2026.”
Market Outlook and Looking Ahead
Kilroy’s strategic focus on life science properties is evident in its development pipeline, with the 10-Q highlighting that “Kilroy has a growing life science portfolio” with operations in “regions within the nation’s top 10 life science markets.”
The company continues to face challenges with its occupancy rates across major markets, with Los Angeles showing 72.7 percent occupancy, San Diego at 87.5 percent, San Francisco Bay Area at 86.8 percent, Seattle at 78.6 percent, and Austin at 76.4 percent, according to the quarterly report.
As Kilroy navigates these market challenges, its future development pipeline, comprising eight future projects across its core markets with the potential for more than 6 million square feet of office space and approximately 1,750 residential units, will be critical to its long-term growth strategy.
The market’s response to Kilroy’s strategic transition toward life science properties and premium office environments will be closely watched in coming quarters as investors look for signs of stabilization in the company’s core markets and improvement in its financial performance.
